Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-29T20:20:06.624Z Has data issue: false hasContentIssue false

Battery for assessment of neuropsychological status (RBANS) in schizophrenia: a pilot study in the Spanish population*

Published online by Cambridge University Press:  24 June 2014

Juan C. Sanz*
Affiliation:
Psychology Unit, Psychiatric Hospital of Mérida, Mérida, Spain
Martín L. Vargas
Affiliation:
Department of Psychiatry, Complejo Asistencial de Zamora, Zamora, Spain
Juan J. Marín
Affiliation:
Psychology Unit, Psychiatric Hospital of Mérida, Mérida, Spain
*
Juan Carlos Sanz, Psychology Unit, Psychiatric Hospital of Mérida, Carretera de Valverde, Km 2, 06800 Mérida (Badajoz), Spain. Tel: +34-924/388081; Fax: +34-934/388083; E-mail: jcsantor@gmail.com

Abstract

Objectives:

The aims of this study were to research the following issues in a Spanish population of patients with schizophrenia. (a) The sensitivity and reliability of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to detect cognitive impairment in schizophrenia. (b) The convergent validity of RBANS on a larger battery of neuropsychological tests sensitive to the cognition disorders typically observed in schizophrenia. (c) The correlates of poor performance in RBANS with clinical features and illness severity.

Method:

Thirty schizophrenia patients, 30 non-psychotic patients and 30 healthy participants were assessed using RBANS (form A). We administered a battery of neuropsychological tests and four scales to evaluate patient’s clinical status.

Results:

Schizophrenia patients and non-psychotic patients performed significantly worse than healthy controls on RBANS, and schizophrenia patients performed slightly worse than non-psychiatric controls, but this difference was not significant. Good inter-test reliability and concurrent validity were found. Only a moderate correlation between RBANS performance and illness severity was observed.

Conclusions:

RBANS revealed coherence in identifying cognitive impairment in schizophrenia patients of a different cultural background, and it is shown to be a sensitive, valid and easy-to-perform tool for the neuropsychological assessment of Spanish patients with schizophrenia.

Type
Research Article
Copyright
Copyright © 2009 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sharma, T, Antonove, L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am 2003;26:2540. CrossRefGoogle ScholarPubMed
Zakzanis, K, Leach, L, Kaplan, E. Schizophrenia in neuropsychological differential diagnosis. Lisse: Sweets & Zetlinger b.v, 1999. Google Scholar
Hoff, AL, Kremen, WS. Neuropsychology in Schizophrenia: an update. Curr Opin Psychiatry 2003;16:149155. CrossRefGoogle Scholar
Sitskoorn, MM, Aleman, A, Ebisch, SJH, Appels, MCM, Kahn, RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 2004;71:285295. CrossRefGoogle ScholarPubMed
Spaulding, WD, Fleming, SK, Reed, D, Sullivan, M, Storzbach, D, Lam, M. Cognitive functioning in Schizophrenia: implications for psychiatric rehabilitation. Schizophr Bull 1999;25:275289. CrossRefGoogle ScholarPubMed
Goldberg, TE. Towards brief assessment of cognitive function in clinical trials and practice. In: Keefe, RSE, ed. Improving cognitive function in the schizophrenic patient. London: Science Press, 1999:4450. Google Scholar
Randolph, CH. Repeatable battery for the assessment of neuropsychological status. San Antonio: The Psychological Corporation, 1998. Google ScholarPubMed
Gold, JN, Queern, CQ, Iannone, VN, Buchanan, RW. Repeatable battery for the assessment of neuropsychological status as a screening test in Schizophrenia, I: sensitivity, reliability, and validity. Am J Psychiatry 1999;156:19441950. CrossRefGoogle ScholarPubMed
Wilk, CH, Gold, JN, Humber, K, Dickerson, F, Fenton, WS, Buchanan, RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable battery for the assessment of neuropsychological status. Psychiatry Res 2004;70:175186. Google ScholarPubMed
Loughland, CM, Lewin, TJ, Vaughan, JC, Sheedy, J, Harris, AW. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings. Schizophr Res 2007;89:234242. CrossRefGoogle ScholarPubMed
Holzer, L, Chinet, L, Jaugey, Let al. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology. Schizophr Res 2007;95:4853. CrossRefGoogle ScholarPubMed
Randolph, C, Tierney, MD, Mohr, E, Chase, TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998;20:310319. CrossRefGoogle ScholarPubMed
Dickerson, F, Boronow, JJ, Stallings, C, Origoni, AE, Cole, SK, Yolken, RH. Cognitive functioning in schizophrenia and bipolar disorder: comparisons of performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Psychiatry Res 2004;129:4553. CrossRefGoogle Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000. Google Scholar
Muntal, S, Dolors, B, Zaragoza, S, Aguilar, M. RBANS-A: translation and adaptation form Spanish people. In: Haaland, K, ed. Proceedings of the Thirty-Second Annual International Neuropsychological Society Conference. Baltimore, MD. New York: Cambridge University Press, 2004: 86. Google Scholar
Kolb, B, Whishaw, IQ. Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurological patients. J Nerv Ment Dis 1983;171:435443. CrossRefGoogle ScholarPubMed
Golden, CH. Stroop color and word test manual for clinical and experimental uses. Wood Dale: Stoelting Company, 1978. Google Scholar
Reitan, RM. Manual for administration of neuropsychological tests batteries for adults and children. Tucson, AZ: Neuropsychology Press, 1979. Google Scholar
Benedet, MJ, Alejandre, MA. Tavec Test de Aprendizaje Verbal España – Complutense. Madrid: TEA Ediciones SA, 1988. Google Scholar
Rey, A. L’ examen clinique en psychologie, 2nd edn. Paris: Presses universitaires de France, 1964. Google Scholar
Weschsler, D. WAIS-III administration and scoring manual. San Antonio, TX: Psychological Corporation, 1997. Google Scholar
Guy, W. Early Clinical Drug Evaluation (ECDEU) assessment manual. Rockville: National Institute Mental Health, 1976. Google Scholar
Kay, SR, Opler, LA, Fiszbein, A. Positive and negative syndrome scale (PANSS). Rating manual. New York: Albert Einstein College of Medicine, 1986. Google Scholar
Simpson, GN, Angus, JWS. A rating scale for extrapiramidal side effects. Acta Psychiatr Scand 1970;212:1119. CrossRefGoogle Scholar
Jolliffe, J. Principal component analysis. New York: Springer-Verlag, 1986. CrossRefGoogle Scholar
Hobart, MP, Goldberg, R, Bartko, JJ, Gold, JN. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic comparisons. Am J Psychiatry 1999;156:19511957. CrossRefGoogle Scholar
Hughes, C, Kumari, V, Soni, Wet al. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Psychiatry Res 2002;59:137146. Google Scholar
Green, MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry 2006;67:3642;67. CrossRefGoogle ScholarPubMed
Pino, O, Guilera, G, Gómez, J, Rojo, E, Vallejo, J, Purdon, SE. Escala breve para evaluar el deterioro cognitivo en pacientes psiquiátricos. Psicothema 2006;18:447452. Google Scholar